Cargando…

Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer

Prediction of outcome in patients with metastatic breast cancer remains problematical. The present study evaluated the value of an inflammation-based score (Glasgow Prognostic Score, GPS) in patients with metastatic breast cancer. The GPS was constructed as follows: patients with both an elevated C-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murri, A M Al, Bartlett, J M S, Canney, P A, Doughty, J C, Wilson, C, McMillan, D C
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2006
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361117/ https://www.ncbi.nlm.nih.gov/pubmed/16404432 http://dx.doi.org/10.1038/sj.bjc.6602922

Ejemplares similares

Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer
por: Al Murri, A M, et al.
Publicado: (2007)

The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer
por: Murri, AM Al, et al.
Publicado: (2008)

Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer
por: Crumley, A B C, et al.
Publicado: (2006)

Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer
por: Forrest, L M, et al.
Publicado: (2004)

Comparison of tumour-based (Petersen Index) and inflammation-based (Glasgow Prognostic Score) scoring systems in patients undergoing curative resection for colon cancer
por: Roxburgh, C S D, et al.
Publicado: (2009)

Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems
por: Lamb, G W A, et al.
Publicado: (2012)

An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
por: Proctor, M J, et al.
Publicado: (2011)

Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer
por: Guthrie, G J K, et al.
Publicado: (2013)

The relationship between deprivation, tumour stage and the systemic inflammatory response in patients with primary operable breast cancer
por: Al Murri, A M, et al.
Publicado: (2004)

A clinical risk score to predict 3-, 5- and 10-year survival in patients undergoing surgery for Dukes B colorectal cancer
por: McMillan, D C, et al.
Publicado: (2010)

To Drive or Not to Drive: Assessment Dilemmas for GPs
por: Sims, J., et al.
Publicado: (2012)

Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable
por: Vogl, U M, et al.
Publicado: (2006)

Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer
por: Jiang, X, et al.
Publicado: (2012)

A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer
por: Forrest, L M, et al.
Publicado: (2005)

S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study
por: Elhassan, Y S, et al.
Publicado: (2021)

Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study
por: Awada, A, et al.
Publicado: (2008)

Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer
por: Canna, K, et al.
Publicado: (2004)

Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer
por: Moyes, L H, et al.
Publicado: (2009)

Baseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinoma
por: Cella, D, et al.
Publicado: (2012)

Metastatic melanoma: prognostic factors and survival in patients with brain metastases
por: Frinton, E., et al.
Publicado: (2017)

The impact of young age on cancer-specific and non-cancer-related survival after surgery for colorectal cancer: 10-year follow-up
por: McMillan, D C, et al.
Publicado: (2009)

The impact of old age on cancer-specific and non-cancer-related survival following elective potentially curative surgery for Dukes A/B colorectal cancer
por: McMillan, D C, et al.
Publicado: (2008)

An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer
por: Crumley, A B C, et al.
Publicado: (2006)

Complete metastasectomy in renal cell carcinoma: a propensity-score matched by the International Metastatic RCC Database Consortium prognostic model
por: Fares, Aline F, et al.
Publicado: (2019)

Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer
por: Pinato, D J, et al.
Publicado: (2014)

Validation of a new prognostic index score for disseminated nasopharyngeal carcinoma
por: Toh, C-K, et al.
Publicado: (2005)

Prognostic Factors and Metastatic Patterns in Primary Myxoid/Round-Cell Liposarcoma
por: Haniball, J., et al.
Publicado: (2011)

The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer
por: McKernan, M, et al.
Publicado: (2008)

Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma
por: Motzer, R J, et al.
Publicado: (2013)

The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study
por: Proctor, M J, et al.
Publicado: (2010)

The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2− breast cancer patients
por: Dubsky, P, et al.
Publicado: (2013)

Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours
por: Tovey, S M, et al.
Publicado: (2009)

Pretreatment Thrombocytosis as a Prognostic Factor in Metastatic Breast Cancer
por: Stravodimou, Athina, et al.
Publicado: (2013)

Evaluation of prognostic factors in liver-limited metastatic colorectal cancer: a preplanned analysis of the FIRE-1 trial
por: Giessen, C, et al.
Publicado: (2013)

Concomitant Drugs Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Receiving Ipilimumab and Nivolumab in the Compassionate Use Program in Italy: Brief Communication
por: Buti, Sebastiano, et al.
Publicado: (2023)

Are GPs under-investigating older patients presenting with symptoms of ovarian cancer? Observational study using General Practice Research Database
por: Tate, A R, et al.
Publicado: (2010)

Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
por: Lobbezoo, D J A, et al.
Publicado: (2015)

Prognostic and predictive value of plasma testosterone levels in patients receiving first-line chemotherapy for metastatic castrate-resistant prostate cancer
por: de Liaño, A G, et al.
Publicado: (2014)

Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring
por: Jones, A L, et al.
Publicado: (2009)

Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas
por: Jamieson, N B, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_ik5kmvmnob8d2d8161sb6lic1r